Document is current
Any future updates will be listed below
-
Authors
Oehrn, Carina R. https://orcid.org/0000-0001-8451-7960
Cernera, Stephanie
Hammer, Lauren H.
Shcherbakova, Maria
Yao, Jiaang https://orcid.org/0000-0001-7062-2508
Hahn, Amelia
Wang, Sarah
Ostrem, Jill L.
Little, Simon https://orcid.org/0000-0001-6249-6230
Starr, Philip A. https://orcid.org/0000-0003-2733-4003
-
Funding
Funding for this research was provided by:
Thiemann Foundation
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (F32NS129627, R25NS070680, R01 NS131405-01, UH3NS100544, R01 NS131405-01, UH3NS100544, R01 NS131405-01, UH3NS100544, R01 NS131405-01, UH3NS100544, K23NS120037, UH3NS100544, R01 NS131405, UH3NS100544, R01 NS090913, U24 NS113637)
TUYF Charitable Trust Fund
- License Information
-
More Information
Article History
Received: 4 January 2024
Accepted: 15 July 2024
First Online: 19 August 2024
Competing interests
: S.L. consults for Iota Biosciences. J.L.O. reports support from Medtronic and Boston Scientific for research and education and consults for AbbVie and Rune Labs. P.A.S. receives support from Medtronic and Boston Scientific for fellowship education. C.R.O., S.C., L.H.H., M.S., J.Y., A.H. and S.W. declare no competing interests.
